Neoadjuvant Osimertinib and Chemotherapy for Stage IIIA Primary Pulmonary Carcinosarcoma with EGFR 19DEL Mutation: A Case Report
Frontiers in Oncology（2023）
Key words
osimertinib,chemotherapy,neoadjuvant,pulmonary carcinosarcoma,EGFR
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined